Clinical Trial Update: Artificial Intelligence Guided Echocardiographic Screening of Rare Diseases (EchoNet-Screening)

View source ↗

Summary

A Cedars-Sinai-led trial is evaluating AI-guided echocardiography to screen for cardiac amyloidosis and other rare diseases. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Cardiac Amyloidosis | Status: RECRUITING